Enrocare 25mg/ml Concentrate for Oral Solution
Manufacturer: Animal Care Group plc
Enrocare 25mg/ml Concentrate for Oral Solution is indicated for the following use:
For the treatment of infections of the digestive and respiratory tracts caused by enrofloxacin susceptible strains of: Escherichia coli, Pasteurella multocida and Staphylococcus spp.
For the treatment of skin and wound infections caused by enrofloxacin susceptible strains of Staphylococcus aureus.
Rodents, Reptiles and Ornamental Birds
Treatment of infections of the digestive and respiratory tracts where clinical experience, if possible, supported by susceptibility testing of the casual organism, indicates enrofloxacin as the substance of choice.
Each 1m Contains:
Active Substance: Enrofloxacin 25mg
Excipient: Benzyl Alcohol 14mg
POM-V | Enrocare Oral Solution